IL-15 PROCYTOKINE ANTIBODY FUSION PROTEINS

MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN THERAPY

VARIABLE REGIONS FOR NKP46 BINDING PROTEINS

CONTORSBODY - A SINGLE CHAIN TARGET BINDER

IL12RB1-BINDING MOLECULES AND METHODS OF USE

BINDING AGENTS TARGETING TUMORS AND/OR IMMUNE CELLS

MSLN AND CD3 BINDING AGENTS AND METHODS OF USE THEREOF

VISTA ANTIGEN-BINDING MOLECULES

TRIFAB-CONTORSBODY

MESOTHELIN-TARGETED CD40 AGONISTIC MULTISPECIFIC ANTIBODY CONSTRUCTS FOR THE TREATMENT OF SOLID TUMORS

METHODS OF ENGINEERING TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Fab-Based Trispecific Antibodies

ANTIBODIES BINDING TO CD30 AND CD3

LAG-3-Binding Molecules and Methods of Use Thereof

Bispecific Antibodies with Charge Pairs and Uses Thereof

Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV Core Antigen

THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE

TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS

BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4

HUMANIZED ANTIBODY AGAINST TNFR2 AND USE THEREOF

HUMAN CD3 BINDING ANTIBODY

ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

FC-ENHANCED ANTIBODIES FOR PREVENTION AND TREATMENT OF EBOLA VIRUS INFECTION

ASSEMBLY OF BISPECIFIC ANTIBODIES

FC Monomer Polypeptide and Application Thereof

AUTOIMMUNE SUPPRESSOR AND APPLICATION THEREOF

MONOCLONAL ANTIBODIES AGAINST C-MET

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

A BISPECIFIC ANTIBODY TARGETING GPC3 AND CD47

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

ENGINEERED ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF

ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTS

MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS

ANTI-VEGF HEXAMERIC ANTIBODY AND COMPOSITION COMPRISING SAME

CONDITIONALLY ACTIVATED ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

ENGINEERED MULTI-SPECIFIC ANTIBODIES AND RELATED METHODS OF USE AND MANUFACTURE

BISPECIFIC ANTIBODY WHICH BINDS TO CD40 AND EpCAM

TRANSFERRIN RECEPTOR BINDING PROTEINS AND CONJUGATES

MULTIVALENT BINDING MOLECULES

Methods for Producing Fabs and IgG Bispecific Antibodies

SARS-COV-2 ANTIBODIES

ANTIBODY CONSTRUCTS

Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-engineering

HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF

PROTEIN CONTAINING HETERODIMER ANTIBODY FC, AND PREPARATION METHOD THEREFOR

ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED ANTIBODY VARIABLE REGION

ENGINEERED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES

AGONISTIC ANTI-IL-2R ANTIBODIES AND METHODS OF USE

CANINE ANTIBODY VARIANTS

CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS

Bispecific antibody binding BCMA and CD3

Anti-PD-1 Antibodies and Fusion Proteins

TAU-BINDING ANTIBODIES

HOMODIMERIC AND HETERODIMERIC PROTEINS COMPRISING BUTYROPHILIN

FC BINDING FRAGMENTS COMPRISING A PD-L1 ANTIGEN-BINDING SITE

ANTIBODIES THAT MODULATE A BIOLOGICAL ACTIVITY EXPRESSED BY A CELL

BISPECIFIC ANTIBODY BINDING TO CD3

PSEUDOFAB-BASED MULTISPECIFIC BINDING PROTEINS

FELINE ANTIBODY VARIANTS

AFFINITY-BASED METHODS FOR USING TRANSFERRIN RECEPTOR-BINDING PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

BISPECIFIC ANTIBODY SIMULTANEOUSLY BINDING TO INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT AND INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT, AND USE THEREOF

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

TRISPECIFIC ANTI-CD38, ANTI-CD28, AND ANTI-CD3 BINDING PROTEINS AND METHODS OF USE FOR TREATING VIRAL INFECTION

IL-21 polypeptides and targeted constructs

BISPECIFIC ANTIBODY

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

SYNTHETIC IMMUNOGLOBULIN DOMAINS WITH BINDING PROPERTIES ENGINEERED IN REGIONS OF THE MOLECULE DIFFERENT FROM THE COMPLEMENTARITY DETERMINING REGIONS

Methods and means for the production of Ig-like molecules

ANTI-CD28 X ANTI-MSLN ANTIBODIES

COMPOSITION OF TRIAX ANTIBODIES AND METHOD OF MAKING AND USING THEREOF

IL-21 polypeptides and targeted constructs

CHIMERIC ANTIGEN RECEPTOR (CAR) WITH CD28 TRANSMEMBRANE DOMAIN

Vaccine Compositions and Antibodies For Lyme Disease

ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME

METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX

ANTI-IDIOTYPIC ANTIBODIES TO ROR1-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF AN EXPRESSION-ENHANCING LOCUS

INERT FORMAT

B7-H4 Antibodies and Anti-B7-H4 Antibody/IL-15 Fusion Proteins

Compositions and methods of use for treating metabolic disorders

NUCLEIC ACIDS ENCODING A POLYPEPTIDE COMPRISING A MODIFIED FC REGION OF A HUMAN IGG1 AND AT LEAST ONE HETEROLOGOUS ANTIGEN

MULTISPECIFIC BINDING PROTEIN OF IMMUNE CELL ENGAGER, PREPARATION THEREFOR AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING CELLS

IL10RB binding molecules and encoding nucleic acids

IL27RAlpha binding molecules and methods of use

ANTIGEN-BINDING PROTEINS AND RELATED METHODS OF USE

Bispecific antibody

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors

Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases

IL12 receptor synthetic cytokines and methods of use

IL10 agonists and methods of use thereof

ANTIBODIES THAT BIND PSMA AND GAMMA-DELTA T CELL RECEPTORS

IFNGR binding synthetic cytokines and methods of use

Methods of treating neutorpenia using G-CSF protein complex

MODIFYING BINDING MOLECULES TO MINIMIZE PRE-EXISITING INTERACTIONS

HUMAN RECOMBINANT ACE2-FC MUTANTS THAT DECOUPLE ANTI-SARS-COV-2 ACTIVITY FROM CARDIOVASCULAR EFFECTS

FC MUTANTS WITH MODIFIED FUNCTIONAL ACTIVITY

ANTI-CD28 COMPOSITIONS

High concentration anti-C5 antibody formulations

FELINE ANTIBODY VARIANTS FOR IMPROVING STABILITY

IMMUNE CELL COMPRISING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

Antibody that binds ErbB-2 and ErbB-3

Agonistic anti-IL-2R antibodies and methods of use

ANTIGEN BINDING CONSTRUCTS TARGETING HER2 AND USES THEREOF

Methods of engineering transferrin receptor binding polypeptides

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

PRODUCTION OF HETERODIMERIC PROTEINS

CHIMERIC ANTIGEN RECEPTORS TARGETING CD33

BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS

Trispecific binding proteins, methods, and uses thereof

METHODS AND MEANS FOR THE PRODUCTION OF IG-LIKE MOLECULES

Bispecific Antibody Or Antigen-Binding Fragment Thereof, And Preparation Method Therefor

HETERODIMERIC PROTEINS

MULTI-SPECIFIC IMMUNE MODULATORS

MULTISPECIFIC HEAVY CHAIN ANTIBODIES WITH MODIFIED HEAVY CHAIN CONSTANT REGIONS

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

ANTI-ROR-2 ANTIBODIES AND METHODS OF USE

T-CELL BISPECIFIC BINDING PROTEINS

FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING

ANTI-LAMBDA MYELOMA ANTRIGEN (LMA) BINDING PROTEINS TO TREAT LMA-EXPRESSING CANCER AND AUTOIMMUNE DISORDERS

Antibody compositions comprising Fc mutations and site-specific conjugation properties for use in treating cancer, immunological disorders, and methods thereof

MULTISPECIFIC ANTIBODY AND METHOD FOR PRODUCING SAME

ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIB

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS

Antibodies binding to CD30 and CD3

PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF

COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE

HETERODIMERIC PROTEINS WITH FC MUTATIONS

FUSION PROTEIN COMPRISING PD-L1 PROTEIN AND USE THEREOF

Bispecific antigen binding constructs targeting HER2

POLYPEPTIDE VARIANTS AND USES THEREOF

HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS

ANTIBODIES COMPRISING SITE-SPECIFIC GLUTAMINE TAGS, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE

MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137

HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF

FUSION ANTIBODY FOR PRESENTING ANTIGEN-DERIVED T CELL ANTIGEN EPITOPE OR PEPTIDE CONTAINING SAME ON CELL SURFACE, AND COMPOSITION COMPRISING SAME

BISPECIFIC PROTEINS AND METHODS FOR PREPARING SAME

MULTISPECIFIC ANTIBODIES

HOMODIMERIC PROTEIN CONSTRUCTS

IgE Antibody with Fcgamma Receptor binding

Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein

ANTIBODY CONSTRUCTS BINDING 4-1BB AND TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF

ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Structures for Reducing Antibody-Lipase Binding

NOVEL MULTISPECIFIC ANTIBODY FORMAT

METHODS OF TREATING PREGNANCY-ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME USING AN ANTI-C5 ANTIBODY

Modified immunoglobulins

EXPRESSION OF SEQUENCE-ENGINEERED LAMBDA ANTIBODY LIGHT CHAINS

PD-1 binding domains

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

Heterodimeric proteins for modulating gamma delta T cells

IMMUNOCYTOKINE COMPRISING HETERODYMERIC PROTEIN COMPLEX BASED ON IL-15/IL-15RA

SINGLE CHAIN VH AND HEAVY CHAIN ANTIBODIES

A NOVEL ANTI-CD3/ANTI-EGFR BISPECIFIC ANTIBODY AND USES THEREOF

ANTI-CD3 ANTIBODIES AND METHODS OF USE

Antibodies specific for CD70 and their uses

ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR MAKING AND USING MULTISPECIFIC ANTIBODIES

PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF

Heterodimeric antibodies that bind CD3 and CD38

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Compositions and Methods for Inhibiting T Cell Exhaustion

ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULES

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3

IgE Antibody with FcRn binding

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

TRANSGENE GENETIC TAGS AND METHODS OF USE

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS

Orthogonal mutations for heterodimerization

CD123 binding proteins and related compositions and methods

MULTISPECIFIC ANTIBODIES

CD3 BINDING MOLECULES

DNMT3A KNOCKOUT CAR T CELLS FOR ADOPTIVE IMMUNOTHERAPY

ENGINEERED IMMUNOGLOBULINS WITH ALTERED FCRN BINDING

MODIFIED FC REGION

SPLIT INTEIN AND PREPARATION METHOD FOR RECOMBINANT POLYPEPTIDE USING THE SAME

MODIFIED HUMAN IGM CONSTANT REGIONS FOR MODULATION OF COMPLEMENT-DEPENDENT CYTOLYSIS EFFECTOR FUNCTION

CONSTRUCTION OF CHIMERIC ANTIGEN RECEPTOR TARGETING CD20 ANTIGEN AND ACTIVITY IDENTIFICATION OF ENGINEERED T CELLS THEREOF

HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM

Complement C2 Binding Proteins and Uses Thereof

MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2

Multivalent FZD and WNT Binding Molecules and Uses Thereof

Immunomodulation and anti-tumor-related nanobody and nucleic acid encoding sequence thereof, and uses of the same

Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity

CHIMERIC PROTEINS IN AUTOIMMUNITY

MODIFIED FC-REGIONS TO ENHANCE FUNCTIONAL AFFINITY OF ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF

Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof

IL-38-SPECIFIC ANTIBODIES

Anti-CHIKV antibodies and uses thereof

FCRN ANTAGONISTS AND METHODS OF USE

FUSION OF AN ANTIBODY BINDING CEA AND 4-1BBL

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS

Anti-IL1RAP antibody compositions

ANTI-MESOTHELIN ANTIBODIES

Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

ANTIBODIES BINDING TO GPRC5D

CHIMERIC PROTEIN EXPRESSING T-CELLS

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

IL-6Ralpha/IL-8R BISPECIFIC BINDING AGENTS FOR INHIBITING CANCER CELL MIGRATION

BISPECIFIC BINDING PROTEINS AND USES THEREOF

ANTI-PD-1/LAG3/TIGIT TRISPECIFIC ANTIBODIES AND ANTI-PD-1/LAG3 BICPECIFIC ANTIBODIES

PROTEIN COMPLEX BY USE OF A SPECIFIC SITE OF AN IMMUNOGLOBULIN FRAGMENT FOR LINKAGE

Anti-polyubiquitin multispecific antibodies

Therapeutic vaccine for Hepatitis B virus (HBV) using the HBV core antigen

ENGINEERING THE HINGE REGION TO DRIVE ANTIBODY DIMERIZATION

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

ANTI-ROR1 / ANTI-CD3 BISPECIFIC BINDING MOLECULES

Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

T cell activating bispecific antigen binding molecules

T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

MULTISPECIFIC TREG BINDING MOLECULES

COMPOSITIONS AND METHODS FOR AUGMENTING ANTIBODY MEDIATED RECEPTOR SIGNALING

Efflux Pump-Cancer Antigen Multi-Specific Antibodies and Compositions, Reagents, Kits and Methods Related Thereto

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16 FOR CANCER TREATMENT

IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS

BINDING MOLECULES BINDING PD-L1 AND LAG-3

LAG-3 binding members

HETEROMULTIMERIC PROTEINS AND METHODS OF USE THEREOF

CELLS EXPRESSING A RECOMBINANT RECEPTOR FROM A MODIFIED TGFBR2 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS

Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR libraries

TWO CHIMERIC ANTIGEN RECEPTORS SPECIFICALLY BINDING CD19 AND IGKAPPA

METHOD FOR THE GENERATION OF A MULTIVALENT, BISPECIFIC ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION

METHOD FOR THE GENERATION OF A BIVALENT, BISPECIFIC ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION

METHOD FOR THE GENERATION OF A TRIVALENT ANTIBODY EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION

ANTI-SIRPalpha MONOCLONAL ANTIBODIES AND USES THEREOF

T CELL RECEPTORS AND METHODS OF USE THEREOF

Heterodimeric antibodies that bind CD3 and tumor antigens

CH3 DOMAIN VARIANT PAIR INDUCING FORMATION OF HETERODIMER OF HEAVY CHAIN CONSTANT REGION OF ANTIBODY AT HIGH EFFICIENCY, METHOD FOR PREPARING SAME, AND USE THEREOF

METHOD FOR THE EXPRESSION OF AN ANTIBODY-MULTIMER-FUSION

MULTIMERS

Anti-MET antibodies and uses thereof

CHIMERIC RECEPTOR THAT RECOGNIZES ENGINEERED SITE IN ANTIBODY

J591 MINIBODIES AND CYS-DIABODIES FOR TARGETING HUMAN PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND METHODS FOR THEIR USE

MULTISPECIFIC ANTIGEN BINDING PROTEINS

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

PRODUCING COMPOSITIONS COMPRISING TWO OR MORE ANTIBODIES

Trispecific and/or trivalent binding proteins

Bispecific antibodies which bind blood coagulation factor VIII and have enhanced activity, and methods of use thereof for treating bleeding and associated conditions

FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE

Anti-CD28 compositions

Fc variants with altered binding to FcRn

BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITION AND USES THEREOF

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

MODIFIED FC FRAGMENT, ANTIBODY COMPRISING SAME, AND APPLICATION THEREOF

Anti-CD28 compositions

Anti-glyco-MUC1 antibodies and their uses

BISPECIFIC ANTIBODIES WITH CLEAVABLE C-TERMINAL CHARGE-PAIRED TAGS

METHOD FOR LARGE SCALE PRODUCTION OF ANTIBODIES USING A CELL-FREE PROTEIN SYNTHESIS SYSTEM

C-terminal lysine conjugated immunoglobulins

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

Antibodies with improved stability to intestinal digestion, polynucleotides thereof and methods of use thereof to treat disease

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains

Multispecific antibodies against CD40 and CD137

COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CTLA-4

Drug regulated transgene expression

ANTIBODY CONSTANT REGION VARIANT

ANTI-CD39 ANTIBODIES

Caninized human antibodies to human IL-4R alpha

TETRAVALENT MULTISPECIFIC ANTIBODIES

Compositions and methods related to engineered Fc constructs

ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137

Heterodimeric antibodies that bind CD3 and tumor antigens

Anti-CD38 antibodies and methods of use

Combination Therapy for the Treatment of Cancer

THERAPEUTIC MULTISPECIFIC POLYPEPTIDES ACTIVATED BY POLYPEPTIDE CHAIN EXCHANGE

CD3 antigen binding fragment and application thereof

ACTIVATABLE THERAPEUTIC MULTISPECIFIC POLYPEPTIDES WITH EXTENDED HALF-LIFE

GENERATION OF ANTIBODY-DERIVED POLYPEPTIDES BY POLYPEPTIDE CHAIN EXCHANGE

Multispecific antibodies against CD40 and CD137

Compositions and methods related to engineered Fc constructs

ANTIBODIES MODIFIED FOR TRANSGLUTAMINASE CONJUGATION, CONJUGATES THEREOF, AND METHODS AND USES

ANTIBODIES THAT BIND TO NATIVELY FOLDED MYOCILIN

Erythropoietin Analogs For Veterinary Use

Readily isolated bispecific antibodies with native immunoglobulin format

Heterodimer molecule based on CH3 domain, and preparation method and use thereof

ACTIVATABLE BISPECIFIC ANTIBODIES

ENGINEERED BISPECIFIC PROTEINS

METHOD FOR PRODUCING POLYPEPTIDE HETERO-OLIGOMER

ANTI-HER2 POLYPEPTIDES AND METHODS OF USE THEREOF

IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES

Production of heteromultimeric proteins using mammalian cells

Bispecific antigen-binding constructs targeting HER2

ENGINEERED IGA ANTIBODIES AND METHODS OF USE

Antigen-binding constructs targeting HER2

Anti-Met fab-Fc for the treatment of a tumor and/or metastasis